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While telemedicine was
introduced prior to the
pandemic of 2020, the
COVID-19 pandemic
made it more readily
available and more
acceptable to both health
care professionals and
patients.
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Abstract
Importance: During
the COVID-19 pandemic,
telemedicine visits increased
to provide safer access to
healthcare.
Methods: To evaluate the
role of telemedicine in obesity
management during COVID-19,
we conducted a systematic
review to identify barriers in
using this approach to patient
care.
Conclusion: While
necessary, the management of
obesity through telemedicine
was met with patient-specific
and healthcare-specific barriers.
Increased awareness of these
barriers may allow physicians
to better understand patient
interactions via virtual medical
visits.
Introduction
Telemedicine has played a role
in the United States healthcare
system for decades now. It
was most initially utilized as a
means of monitoring astronauts
in flight, established by the
National Aeronautics and Space
Association (NASA) in 1960.1
In more recent years, it has
played a more prevalent role in
certain medical specialties, such
as radiology, psychiatry, and

442 | 118:5 | September/October 2021 | Missouri Medicine

cardiology than others. It has
also allowed for increased interspecialty communication between
healthcare professionals. Its
versatility has been demonstrated
across different settings as well:
ambulatory appointments,
emergency visits, hospital followup, and most recently, testing and
screening for COVID-19.
This article focuses on the
use of telemedicine for patients
struggling with obesity and its
limitations. It is long known that
physicians have tried to manage
obesity in patients through diet
and exercise, then stepping up
to medication, and if all else
fails, bariatric surgery. However,
it is unknown how well these
management plans have succeeded
during a pandemic that has
required virtual medical visits and
extended periods of quarantine.
This is a particularly important
topic to consider because it was
found that obesity has been
associated with an increased risk
of death among hospitalized
patients diagnosed with
COVID-19.2 Additionally, obesity
has become increasingly common
among the population age 50 and
younger, thus shifting the severe
and fatal COVID-19 cases to the
younger population.
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Methods
We conducted a systemic review of the
literature across the PubMed (MEDLINE)
and Elsevier ClinicalKey research databases.
Searches were performed between February
1, 2021, and February 28, 2021, by A. W.
S. The keywords used to search for relevant
articles included telemedicine, telehealth,
virtual visits, COVID-19, coronavirus, obesity,
and weight. We reviewed articles published
between February 1, 2020, and February 1,
2021, and excluded all other articles published
outside of that timeframe. The inclusion criteria
used for PubMed (MEDLINE) included:
free full-text, English language, and humans.
The inclusion criteria used for ClinicalKey
included: full-text only, articles listed under
specialties endocrinology and metabolism,
internal medicine, and surgery. Exclusion
criteria included: articles outside the scope
of the search, articles that included diabetic
patients and diabetes management, articles that
did not focus on medical management during
COVID-19. Using the parameters, 23 articles
from the MEDLINE database and 70 articles
from the ClinicalKey database were obtained.
After exclusion criteria was applied, two articles
from the MEDLINE database and three articles
from the ClinicalKey database were reviewed
and analyzed. Figure 1 illustrates the search
process with the inclusion and exclusion criteria
described above.
Results
Limitations of telemedicine for visits for
obesity management were broken down into
two categories: patient-specific barriers and
healthcare-specific barriers. Limitations that were
included in patient-specific barriers included
access to technology and patient acceptance.3
Although 75% of U.S. adults have internet
service at home, this does not account for the
unequal distribution across racial minorities, the
elderly, those living in rural regions, and those
with lower levels of education and income. This
is particularly relevant to the management of
obesity, as there is a disproportionately higher
obese population among certain racial/ethnic

and socioeconomic classes.4 It was found that
among the age group of 2-5 years, 16.5%
of Hispanic/Latino and 11.6% of Black,
non-Hispanic children fall into the obese
group, whereas 9.9% of White, non-Hispanic
children fall into the same category. These
children are also found to have a higher obesity
risk in adolescence compared to their healthy
weight counterparts. Therefore, children
who are impacted by obesity translates into
a similar adult population demographic also
impacted by obesity. As a result, unfortunately,
the same patient demographic who has a
disproportionately higher rate of obesity also
suffers from more limitations in having access
to telehealth.
In comparison, it has been shown that
established telemedicine practices have
received positive feedback. A Pediatric and
Adolescent Weight and Cardiometabolic
Clinic in Orono, Maine, had established
a weight management clinic with a full
interdisciplinary team and IT experts to set
up a telemedicine plan for patients in 2015,
before the COVID-19 pandemic. It was
concluded that the telemedicine services,
in fact, reduced barriers to access including
reduced travel time, decreasing competing
responsibilities, less absence from work,
avoidance of inclement weather, and allowing
patients to be in a home environment where
they are most comfortable.5 The technological
and socioeconomic disparities are briefly
touched upon by the author, but the benefits
listed contributed a different and interesting
perspective in adding telemedicine practices
for obesity management as an adjunct to
traditional office visits in the future.
In addition to the benefits that the clinic
in Orono, Maine, has listed, telemedicine
has also been found to be beneficial with
regards to increasing access to bariatric surgery
programs. Many of the screening process steps
for bariatric surgery, questions that patients
may have, and initial informational sessions
can all be addressed and presented to patients
remotely.6 This also increases the number of
participants per session, thus further increasing
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the number of patients who have access to this
information. The argument for why traditional
office visits have not been as successful with
bariatric surgery is due to lengthy process
patients have to go through in order to get
cleared for surgery, making it a cumbersome and
demoralizing process. It has been shown that less
than 1% of patients eligible for bariatric surgery
actually end up undergoing surgery, and 50% of
patients who initiate the process end up dropping
out. This is despite the fact that bariatric
surgery is one of the most effective methods for
treating obesity and its associated comorbidities.
Consequently, telemedicine has proven beneficial
in this very specific, but unique, avenue of obesity
management.
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In addition to patientspecific barriers, limitations
that were included in
healthcare-specific barriers
included healthcare
provider acceptance,
reimbursement, and
regulatory barriers. Changes
in the healthcare system
has also been witnessed
to accommodate this
prevalent implementation
of telemedicine. Previously,
insurance companies had
restrictions on the types of
visits that would receive
reimbursements. However,
to support the widespread
need for virtual visits,
Medicare has broadened
the scope for which it
allows reimbursement for
telemedicine visits under
the 1135 Waiver.7 Outside
of government-funded
healthcare, over 30 states
across the country have
required private insurance
companies to reimburse
providers for telehealth
services. Additionally,
the federal government
have lifted regulatory barriers that prohibit
communication with patients that may
violate the Health Insurance Portability and
Accountability Act as well as lifted restrictions
on providing care across state lines.3 This has
allowed physicians to communicate with patients
via Zoom, Google Hangouts, Apple FaceTime,
and more. These changes have eliminated some
of the restrictions of the level of care physicians
can provide for patients.
Discussion
On a national level, obesity has been
viewed as a sign of personal moral failure and
is not categorized as a disease.6 Consequently,
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this has limited patient access to care, as
well as a patient’s desire to seek out care.
Additionally, obesity has been shown to
affect a disproportionately higher number of
certain racial/ethnic groups and those of lower
socioeconomic and education status.4 With the
COVID-19 pandemic, patients affected with
COVID-19 and who also suffer from obesity,
have a higher severity of the disease and fatality.2
Together, these issues highlight the value of
improving obesity management, during the
COVID-19 pandemic and after.
The widespread application of telemedicine
has both positive and negative impacts on obesity
management. Though positive reviews include
decreased travel time and less stigmatization of
patients seeking bariatric surgery, there are still a
number of barriers that need to be corrected to
deliver fair and accessible telemedicine healthcare
for those in need. This includes overcoming a
lack of resources for patients who do not have
access to, or do not have knowledge of how to
use, the technological aspect of telemedicine.
With the increased utilization of telemedicine, it
may become a role of the physician’s office team
to educate patients on how to use technology
services and how to understand interactions via
a virtual platform. This shift in responsibility
will need to be further evaluated in terms
of the workflow of a physician’s office, the
comfort level of the team, feasibility, and simple
willingness from both parties. Because obesity is
also more prevalent among specific ethnic/racial
and socioeconomic groups, reducing the rate
of obesity in these patient demographics would
help decrease the rate of obesity in general.
However, the scope of this approach would
have to be further evaluated as obesity has been
determined to be a multifactorial and complex
health issue.8,9 We believe that the first step in
addressing these issues is recognition, and from
there, the limitations can begin to be eliminated.
Conclusion
While telemedicine was introduced prior
to the pandemic of 2020, the COVID-19
pandemic made it more readily available

and more acceptable to both health care
professionals and patients. However, like its
counterpart “in-person” practices in medicine,
its limitations need to be identified and
addressed to further improve delivery of care
to patients. More research is needed to identify
the barriers that limit patients’ access to and
use of telemedicine. Before telemedicine can
gain further patient acceptance and meet
the expectations of the traditional model of
healthcare, its barriers need to be understood
and eliminated to provide equitable care for
patients.
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